TEVOGEN BIO HOLDINGS INC.
Last · NasdaqGM$6.506-0.6044 (-8.50%)close · yahoo · 17h ago
Vol 2.5K ≈ 16.2K
MA10MA20MA50
Market cap$42.36M6.5M sh
P/E · TTM-1.0fwd — · eps -6.74 · loss
Beta0.20vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.636$39.00
Volume2.5Ksession
Issuer
Legal nameTEVOGEN BIO HOLDINGS INC.
HQUnited States (US)
ListingUS TVGN
ISINUS88165K2006
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001860871
CIK0001860871
Websitetevogen.com
Employees18
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-31
From latest 10-K · 2026-03-31
- Operating Cf Burn
- Cash Runway Low
- Current Ratio Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.0 years
- Current Ratio Low — Current ratio 0.22
Upcoming earnings
FRI.13NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Press & signals
- GlobeNewswire
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
- GlobeNewswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
- GlobeNewswire
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 50 filings